NCT02523287View on ClinicalTrials.gov

Placebo Controlled Study to Generate Data Characterising Clinical Events, Physiological Responses and Immune Responses

PHASE4CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

October 2, 2014

Primary Completion Date

August 1, 2016

Study Completion Date

August 1, 2016

Conditions
Safety Markers of Adjuvanted Influenza Vaccine
Interventions
BIOLOGICAL

Fluad

Randomized assignment

BIOLOGICAL

Saline

Randomized assignment

Trial Locations (1)

9000

Center for Vaccinology, Ghent

Sponsors
All Listed Sponsors
collaborator

University of Surrey

OTHER

collaborator

Novartis Vaccines

INDUSTRY

collaborator

Max Planck Institute for Infection Biology

OTHER

collaborator

deCODE genetics

INDUSTRY

collaborator

VisMederi srl

INDUSTRY

collaborator

GlaxoSmithKline

INDUSTRY

collaborator

Innovative Medicines Initiative

OTHER

lead

University Hospital, Ghent

OTHER